eSignal IPO Calendar

Week of Expected Pricing	Withdrawn
Company Name	Anacor pharmaceuticals, Inc.
Proposed Ticker	ANAC
CUSIP	N/A
Business Description	A biopharmaceutical company developing novel small-molecule therapeutics derived from our boron chemistry platform.
Lead Underwriter	Morgan Stanley, Cowen and Company
Co-Managers	Pacific Growth Equities
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A